FORT MYERS — NeoGenomics has created tests to identify 22 categories of cancerous tumors that will help doctors treat their patients more effectively, the company announced.
Continue reading your article with a Business Observer subscription.
What's included:
✓ Unlimited digital access to BusinessObserverFL.com
✓ E-Newspaper app, digital replica of print edition